Department of Surgery

The Department of Surgery at MUSC has a strong commitment to provide the highest level of compassionate patient care, best–in–class training for the next generation of surgical leaders, and cutting-edge clinical, basic science, and translational research. Our commitment to innovation and discovery allows us to translate the latest developments, understanding, and technology into improved surgical patient care resulting in less post-operative pain, faster recoveries, and shorter hospital stays.

News and Announcements

Learn about the latest news and events in the MUSC Department of Surgery.

Rana Pullatt, M.D., Elected President of the American Society for Metabolic and Bariatric Surgery

The MUSC Department of Surgery is excited to announce that Rana Pullatt, M.D., an internationally recognized leader in bariatric and robotic surgery, has been elected President of the American Society for Metabolic and Bariatric Surgery (ASMBS).

Evert Eriksson MD Appointed President of the Chest Wall Injury Society

The MUSC Department of Surgery is thrilled to announce that Evert Eriksson, M.D., an internationally recognized leader in chest wall trauma, has been appointed President of the Chest Wall Injury Society (CWIS) for the 2025–26 term.

MUSC Global Surgery Program expands, paves way for transformative change

Two years ago, the MUSC Global Surgery Program was officially born with a bold vision – to transform how residents, medical students, health care professionals and communities worldwide engage with global health issues.

Jon van Heerden, M.D., Named an Icon of Surgery by the American College of Surgeons

The Department of Surgery at MUSC is proud to announce that Jon van Heerden, M.D., internationally renowned endocrine surgeon, educator, and researcher, has been named an Icon of Surgery by the American College of Surgeons.

Hongjun Wang, Ph.D. Receives a $1.5M NIH UH3 Award to Continue her STEMCAP-1 Pain Study for Chronic Pancreatitis

Thanks to a new study being conducted by Hongjun Wang, Ph.D. using mesenchymal stromal cells (MSCs) in treating pain represents a promising novel intervention and has just received additional funding to advance the science.

Improving heart transplant process with AI

Arman Kilic, M.D., director of the Harvey and Marcia Schiller Surgical Innovation Center, has been awarded $1.9M R01 to help shrink the chasm between transplant demand and organ supply.

Make a Gift

Follow Us on Facebook

Follow Us on Twitter